Suppr超能文献

多囊卵巢综合征患者在孕期使用二甲双胍治疗是否安全?

Is metformin therapy for polycystic ovary syndrome safe during pregnancy?

作者信息

Brock Birgitte, Smidt Kamille, Ovesen Per, Schmitz Ole, Rungby Jørgen

机构信息

Department of Clinical Pharmacology, Aarhus Sygehus, DK-8000 Aarhus C, Denmark.

出版信息

Basic Clin Pharmacol Toxicol. 2005 Jun;96(6):410-2. doi: 10.1111/j.1742-7843.2005.pto_02.x.

Abstract

Polycystic ovary syndrome is characterized among other things by oligo-amenorrhea and may account for more than 75% of cases with anoluvatory infertility. Due to its positive effects on polycystic ovary syndrome-induced infertility metformin has become one of the most common drugs used in this group of patients. The efficacy of the drug as well as the first reports on metformin used in pregnancy has encouraged the continued use of the drug after conception. This MiniReview reviews the current pros and cons of metformin use in pregnancy while awaiting the results of ongoing randomised, controlled clinical trials addressing the subject.

摘要

多囊卵巢综合征的特征之一是月经稀发,且可能占无排卵性不孕症病例的75%以上。由于二甲双胍对多囊卵巢综合征所致不孕症有积极作用,它已成为这类患者最常用的药物之一。该药的疗效以及关于孕期使用二甲双胍的首批报告促使人们在受孕后继续使用该药。本综述在等待针对该主题的正在进行的随机对照临床试验结果之际,回顾了孕期使用二甲双胍目前的利弊。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验